|
FY2025
12 months to Sep 28, 2025
|
FY2024
12 months to Sep 29, 2024
|
FY2023
12 months to Sep 24, 2023
|
FY2022
12 months to Sep 25, 2022
|
FY2021
12 months to Sep 26, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Income from continuing operations | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Indefinite and long-lived asset impairment charges | |||||
| Income tax provision in excess of (less than) income tax payments | |||||
| Share-based compensation expense | |||||
| Net gains on marketable securities and other investments | |||||
| Impairment losses on other investments | |||||
| Other items | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Other assets | |||||
| Trade accounts payable | |||||
| Payroll, benefits and other liabilities | |||||
| Unearned revenues | |||||
| Net cash used by operating activities from discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Investing Activities: | |||||
| Capital expenditures | |||||
| Purchases of debt and equity marketable securities | |||||
| Proceeds from sales and maturities of debt and equity marketable securities | |||||
| Acquisitions and other investments, net of cash acquired | |||||
| Proceeds from sales of property, plant and equipment | |||||
| Proceeds from other investments | |||||
| Other items | |||||
| Net cash provided by investing activities from discontinued operations | |||||
| Net cash (used) provided by investing activities | |||||
| Financing Activities: | |||||
| Proceeds from short-term debt | |||||
| Repayment of short-term debt | |||||
| Repayment of debt of acquired company | |||||
| Proceeds from long-term debt | |||||
| Repayment of long-term debt | |||||
| Proceeds from issuance of common stock | |||||
| Repurchases and retirements of common stock | |||||
| Dividends paid | |||||
| Payments of tax withholdings related to vesting of share-based awards | |||||
| Other items | |||||
| Net cash provided (used) by financing activities from discontinued operations | |||||
| Net cash used by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease) increase in total cash, cash equivalents and restricted cash | |||||
| Total cash and cash equivalents at beginning of period (including $77 and $326 classified as held for sale at September 24, 2023 and September 25, 2022) | |||||
| Total cash and cash equivalents at end of period (including $2,323 classified as restricted cash at September 28, 2025 and $77 classified as held for sale at September 24, 2023) | |||||
| Beginning Balance - Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents | |||||
| Ending Balance - Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents | |||||
| Beginning Balance - Restricted Cash | |||||
| Ending Balance - Restricted Cash | |||||
Loading...